As of Aug 28
| +0.47 / +10.56%|
The 2 analysts offering 12-month price forecasts for SkyePharma PLC have a median target of 6.30, with a high estimate of 7.14 and a low estimate of 5.45. The median estimate represents a +28.02% increase from the last price of 4.92.
The current consensus among 2 polled investment analysts is to Buy stock in SkyePharma PLC. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.